Total Return chart Oramed Pharmaceuticals Inc.
Stocks
ORMP
US68403P2039
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 4.160 USD | +1.96% |
|
+0.24% | +45.96% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Oramed Pharmaceuticals Inc.
| 2026-01-15 | 0.25 USD |
- Stock Market
- Stocks
- ORMP Stock
- Charts Oramed Pharmaceuticals Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
